Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Next-generation Sequencing03:00

Next-generation Sequencing

96.6K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
96.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cenobamate in pediatric epilepsy: Moving beyond anecdotal experience.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society·2026
Same author

Phenotype and Genetics of Spinocerebellar Ataxia Type 27B: Novel Movement-disorder Features, Cognitive Impairment, and Repeat Expansion Findings.

Cerebellum (London, England)·2026
Same author

Epilepsy surgery in pediatric patients with complex COL4A1/2-associated epilepsy.

Epileptic disorders : international epilepsy journal with videotape·2026
Same author

Association of behavioral problems and health-related quality of life in children with epilepsy.

Epilepsy & behavior : E&B·2026
Same author

Gene-specific long-term course, neurodevelopmental outcome and quality of life in patients with LIS1/PAFAH1B1-, DCX-, DYNC1H1-, TUBA1A- and TUBG1-related lissencephaly.

Orphanet journal of rare diseases·2026
Same author

Seminars in epileptology: Holistic management of epilepsy in adults with intellectual development disorders.

Epileptic disorders : international epilepsy journal with videotape·2026

Related Experiment Video

Updated: Dec 4, 2025

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

8.9K

Next Generation Sequencing in Pediatric Epilepsy Using Customized Panels: Size Matters.

Eva-Katharina Willimsky1, Anna Munzig2, Karin Mayer2

  • 1Division of Pediatric Neurology, Developmental Medicine and Social Pediatrics Department of Pediatrics, Ludwig-Maximilians University of Munich, Dr. von Hauner Children's Hospital, Munich, Germany.

Neuropediatrics
|October 21, 2020
PubMed
Summary

Large customized epilepsy gene panels significantly increase diagnostic yield in pediatric epilepsy patients without developmental and epileptic encephalopathy (non-DEE). For DEE cases, smaller panels may suffice, while larger panels increase unclear findings.

More Related Videos

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

12.2K
Rare Event Detection Using Error-corrected DNA and RNA Sequencing
10:36

Rare Event Detection Using Error-corrected DNA and RNA Sequencing

Published on: August 3, 2018

12.4K

Related Experiment Videos

Last Updated: Dec 4, 2025

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

8.9K
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

12.2K
Rare Event Detection Using Error-corrected DNA and RNA Sequencing
10:36

Rare Event Detection Using Error-corrected DNA and RNA Sequencing

Published on: August 3, 2018

12.4K

Area of Science:

  • Genetics
  • Neurology
  • Molecular Biology

Background:

  • Next-generation sequencing (NGS) with customized gene panels is crucial for diagnosing monogenic epilepsy syndromes.
  • The size of customized epilepsy gene panels can vary considerably, impacting diagnostic efficiency.

Purpose of the Study:

  • To compare the diagnostic yield of small (<25 kb) versus large (>25 kb) customized epilepsy gene panels.
  • To analyze diagnostic yield differences based on epilepsy severity, specifically developmental and epileptic encephalopathy (DEE) versus non-DEE.

Main Methods:

  • Retrospective cohort study of 190 pediatric patients (≤18 years) with epilepsy of unknown etiology.
  • NGS using customized gene panels was performed, comparing small and large panels for variant classification (benign, likely benign, pathogenic, likely pathogenic, unclear significance).

Main Results:

  • Large panels showed a significantly higher diagnostic yield (29%) compared to small panels (13%) (p=0.0198).
  • In non-DEE patients, large panels yielded significantly more diagnoses (35%) than small panels (13%) (p=0.0378).
  • This significant increase in diagnostic yield for large panels was not observed in DEE patients.

Conclusions:

  • Large customized epilepsy panels (>25 kb) offer superior diagnostic yield for pediatric epilepsy patients, particularly those without DEE.
  • For DEE patients, smaller panels (≤10 genes) may be adequate.
  • Increased panel size correlates with a higher proportion of variants of unclear significance.